Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Alfredo, Marinelli"'
Autor:
Philipp Jurmeister, Stefanie Glöß, Renée Roller, Maximilian Leitheiser, Simone Schmid, Liliana H. Mochmann, Emma Payá Capilla, Rebecca Fritz, Carsten Dittmayer, Corinna Friedrich, Anne Thieme, Philipp Keyl, Armin Jarosch, Simon Schallenberg, Hendrik Bläker, Inga Hoffmann, Claudia Vollbrecht, Annika Lehmann, Michael Hummel, Daniel Heim, Mohamed Haji, Patrick Harter, Benjamin Englert, Stephan Frank, Jürgen Hench, Werner Paulus, Martin Hasselblatt, Wolfgang Hartmann, Hildegard Dohmen, Ursula Keber, Paul Jank, Carsten Denkert, Christine Stadelmann, Felix Bremmer, Annika Richter, Annika Wefers, Julika Ribbat-Idel, Sven Perner, Christian Idel, Lorenzo Chiariotti, Rosa Della Monica, Alfredo Marinelli, Ulrich Schüller, Michael Bockmayr, Jacklyn Liu, Valerie J. Lund, Martin Forster, Matt Lechner, Sara L. Lorenzo-Guerra, Mario Hermsen, Pascal D. Johann, Abbas Agaimy, Philipp Seegerer, Arend Koch, Frank Heppner, Stefan M. Pfister, David T. W. Jones, Martin Sill, Andreas von Deimling, Matija Snuderl, Klaus-Robert Müller, Erna Forgó, Brooke E. Howitt, Philipp Mertins, Frederick Klauschen, David Capper
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-14 (2022)
Sinonasal tumour diagnosis can be complicated by the heterogeneity of disease and classification systems. Here, the authors use machine learning to classify sinonasal undifferentiated carcinomas into 4 molecular classe with differences in differentia
Externí odkaz:
https://doaj.org/article/6b6e398cca1d45b0ab123d7e7294892a
Autor:
Alfredo Marinelli, Mariella Cuomo, Raduan Ahmed Franca, Michela Buonaiuto, Davide Costabile, Cristina Pagano, Federica Trio, Liliana Montella, Maria Laura Del Basso De Caro, Roberta Visconti, Lorenzo Chiariotti, Rosa Della Monica
Publikováno v:
Brain Sciences, Vol 13, Iss 2, p 235 (2023)
Diagnoses of primary malignant mesenchymal brain tumors are a challenge for pathologists. Here, we report the case of a 52-year-old man with a primary brain tumor, histologically diagnosed as a high-grade glioma, not otherwise specified (NOS). The pa
Externí odkaz:
https://doaj.org/article/c97901a2bb884ddbaa4b39cb79f7f17c
Autor:
Liliana Montella, Federica Sarno, Lucia Altucci, Valentina Cioffi, Luigi Sigona, Salvatore Di Colandrea, Stefano De Simone, Alfredo Marinelli, Bianca Arianna Facchini, Ferdinando De Vita, Massimiliano Berretta, Raffaele de Falco, Gaetano Facchini
Publikováno v:
Frontiers in Nutrition, Vol 8 (2021)
Glioblastoma is the most frequent and aggressive brain cancer in adults. While precision medicine in oncology has produced remarkable progress in several malignancies, treatment of glioblastoma has still limited available options and a dismal prognos
Externí odkaz:
https://doaj.org/article/1646b8c8120e4ff8a630df654800a644
Autor:
Manuel Gotti, Irene Defrancesco, Mario D’Angelo, Sabrina Basso, Luca Crotto, Alfredo Marinelli, Cristina Maccalli, Vincenzo Iaconianni
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Chimeric Antigen Receptor-T cells (CAR-T) are considered novel biological agents, designed to selectively attack cancer cells expressing specific antigens, with demonstrated clinical activity in patients affected with relapsed/refractory B-cell malig
Externí odkaz:
https://doaj.org/article/2831880b954647fba1bebfca36b583de
Autor:
Raffaele Addeo, Giuseppe Lamberti, Giorgia Simonetti, Patrizia Iodice, Alfredo Marinelli, Liliana Montella, Salvatore Cappabianca, Paola Gaviani, Michele Caraglia, Salvatore Del Prete, Antonio Silvani
Publikováno v:
CNS Oncology, Vol 8, Iss 2 (2019)
Aim: To assess the efficacy and safety of alternative fotemustine administration schedule in elderly patients with recurrent glioblastoma. Patients & methods: Patients aged >65 years with recurrent glioblastoma received fotemustine (80 mg/m2; days 1,
Externí odkaz:
https://doaj.org/article/73203f976b0042d79d481f1e7470e992
Autor:
Carlo Buonerba, Pietro De Placido, Dario Bruzzese, Martina Pagliuca, Paola Ungaro, Davide Bosso, Dario Ribera, Simona Iaccarino, Luca Scafuri, Antonietta Liotti, Valeria Romeo, Michela Izzo, Francesco Perri, Beniamino Casale, Giuseppe Grimaldi, Francesca Vitrone, Arturo Brunetti, Daniela Terracciano, Alfredo Marinelli, Sabino De Placido, Giuseppe Di Lorenzo
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Sunitinib is the most commonly prescribed drug for advanced renal cell carcinoma in the first-line setting and has been associated with multiple adverse events related to its on–and off–target effects, including hand and foot syndrome and fatigue
Externí odkaz:
https://doaj.org/article/96f44c52c51a4cb880494c4e92bc123a
This contribution illustrates the preliminary results of the research activities carried out within the PhD in Information and Communication Technology for Health (ICTH) on the topic of Delivery Manager of Cognitive Computing for Neuroncology, at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e54e01f0db820ced8ec925034799bcf8
http://hdl.handle.net/11588/893366
http://hdl.handle.net/11588/893366
Autor:
S Facchini, Alfredo Marinelli, Luca Scafuri, Nicola Longo, Sabino De Placido, Felice Crocetto, Guru Sonpavde, Giuseppe Lucarelli, Antonio Verde, Giuseppe Di Lorenzo, Ciro Imbimbo, Daniela Terracciano, Matteo Ferro, Pasquale Dolce, Angelo Vaia, Vincenzo Mirone, Carlo Buonerba, Liliana Montella
Background Both docetaxel and androgen-receptor-axis-targeted (ARAT) agents are approved in metastatic castration-sensitive prostate cancer (mCSPC) patients. Predictive factors of therapy efficacy are lacking. Methods We included articles reporting d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2d2e82ac523c80cf9a6bcb86ff1c99
http://hdl.handle.net/11588/820288
http://hdl.handle.net/11588/820288
Autor:
Luigi Cerbone, Gianfranco Peluso, Nadia Cordua, Alfredo Marinelli, Carlo Buonerba, Giuseppe Di Lorenzo, Sabino De Placido, Giuseppe Lamberti
Publikováno v:
Medicine
Background: Glioblastoma multiforme (GBM) is a rare and deadly disease, with a reported average incidence rate of 3.19 cases per 100,000 inhabitants. Fotemustine, a third-generation nitrosourea with an alanine phosphor carrier that facilitates cellul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4b766ea28d2b8023c846decc045e51c
https://pubmed.ncbi.nlm.nih.gov/29979390
https://pubmed.ncbi.nlm.nih.gov/29979390
Autor:
Michele Caraglia, Salvatore Del Prete, Paola Gaviani, Alfredo Marinelli, Liliana Montella, Antonio Silvani, Salvatore Cappabianca, Giuseppe Lamberti, Patrizia Iodice, Raffaele Addeo, Giorgia Simonetti
Publikováno v:
CNS Oncology
Aim: To assess the efficacy and safety of alternative fotemustine administration schedule in elderly patients with recurrent glioblastoma. Patients & methods: Patients aged >65 years with recurrent glioblastoma received fotemustine (80 mg/m2; days 1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea415771c4b2574d7b354c42aaa6166a
https://doi.org/10.2217/cns-2019-0004
https://doi.org/10.2217/cns-2019-0004